AsiaIntervention

AsiaIntervention is the official journal of the Asian-Pacific Society of Interventional Cardiology @APSIC6 and the Interventional Cardiology Foundation of India

[AsiaIntervention @AsiaInterv]

🔍 Does PCI complexity alter #IVI benefits?
A new RENOVATE-COMPLEX-PCI analysis reveals a major shift in outcomes based on procedural risk.
👇 See which subgroups benefit most:
https://t.co/TPA0H782wG
@APSIC6 @EuroInterventio @PCRonline #CardioTwitter

[EuroIntervention @EuroInterventio]

In this Editorial, Tang and Onishi discuss the potential role of prolonged balloon inflation in optimising valve expansion, highlighting key considerations for procedural strategy.

Read the Editorial: https://t.co/Bp1y2q8TnV

Related Original Article by Cardaioli et al: https://t.co/g62f0sqZ5Y

@cardaioli @GilbertTangMD

[EuroIntervention @EuroInterventio]

In this study by Gim et al., combining CCTA-derived CT-μFR with the lesion-specific CT-μFR gradient improved the prediction of subsequent coronary events over 3 years compared with CT-μFR alone, including in vessels with CT-μFR >0.80.
Read the article here: https://t.co/AqZb4i6l0s

#CCTA #CoronaryPhysiology

[Rajesh Vijayvergiya @DrRajeshVijay]

Pleased to be a co-author of the COMBINE-INTERVENE trial design, published in @Eurointervention. The trial addresses an important question- Can integrating OCT-based plaque assessment with FFR-guided decision-making improve outcomes in patients with multivessel CAD? @AsiaInterv

[AsiaIntervention @AsiaInterv]

⏱️ Can TAVI valve deployment be faster without compromising early safety?
This study evaluates a semi-rapid pacing-assisted workflow for Evolut FX implantation, reducing median device time from 14 to 9 minutes.
🔗 https://t.co/lifNZef1i6
@APSIC6 @EuroInterventio @PCRonline

[AsiaIntervention @AsiaInterv]

🔍 Does patient phenotype dictate #TAVI outcomes? Insights from 6,967 cases comparing distinct baseline risks and anatomy between Japan and France:
🔗https://t.co/I0iG3Nr6mr
@APSIC6 @EuroInterventio @PCRonline @didier_tchetche @nicolasdumonte1 #CardioTwitter

[Zille Huma @Zill_cardio]

Active side branch protection in provisional stenting: techniques, case-based insights, and practical considerations | Expert Review via @AsiaInterv

#ProvisionalStenting #BifurcationPCI #JSKBT @PCRonline @EuroInterventio
#CardioX

🔗https://t.co/RwrIq9evoc

[AsiaIntervention @AsiaInterv]

🔍 New APSIC best practices for safety and effectiveness in the use of ionising radiation.
Mirvat Alasnag et al. provide guidance to reduce exposure & prevent injuries.
👉 Read here: https://t.co/J86H7Zus7f
@APSIC6 @EuroInterventio @PCRonline @mirvatalasnag

[EuroIntervention @EuroInterventio]

Age alone may not adequately reflect prognosis after aortic valve replacement.

In this nationwide Danish cohort, comorbidity burden was a major determinant of observed survival, with implications for lifetime management strategies and valve selection.
Read more here: https://t.co/28T7h1PYez

#TAVI #SAVR

[PCRonline 🫀 @PCRonline]

@Jonyap88 and Angus Shing Fung Chui explore the key procedural challenges of TAVI in bicuspid valves at #AictPCR.

[PCRonline 🫀 @PCRonline]

What guides tool selection in calcified lesions? @jeremyquah88 explores the question with Michael Nguyen at #AictPCR.

[AsiaIntervention @AsiaInterv]

🇸🇬 Live from Singapore at AICT-AsiaPCR!
Our Editor-in-Chief, Professor Upendra Kaul, presented AsiaIntervention during the course. Come meet him and our Local Associate Editor, Dr. Priyadarshini Arambam, directly on-site!
🔗Read the latest issue: https://t.co/8Yk51UVM06
#AictPCR

[PCRonline 🫀 @PCRonline]

Female cardiovascular disease takes centre stage at #AictPCR. @IndahSP_MD speaks with Fazila Malik and @drliminghaan about recognising the patient and her condition, and how to treat. Some insights into the WIN-APSIC initiative as well!

[PCRonline 🫀 @PCRonline]

@aadil_wasil talks with @Dr_AshokSeth at #AictPCR about making complex CTO PCI cases more predictable. 🫀 A discussion full of insights!

#interventionalcardiology

[PCRonline 🫀 @PCRonline]

⏳ This is it! #AictPCR is almost here!

@Ditongaje shares what makes this Course a valuable learning and networking opportunity for interventional cardiology professionals across Asia-Pacific.

🇸🇬 Join us in Singapore, 23–24 October!
https://t.co/yhuQPcDRu7

[EuroIntervention Case Reports @EIJCaseReports]

Deficient rims (<5mm) in adult ASDs?❌ Surgery isn't the only option.
Julio Sauza-Sosa et al. share advanced transcatheter maneuvers (aortic straddling, PV-support & LA roof deployment) to safely achieve 100% percutaneous success 👇
https://t.co/V5SZsp35Ln
#FOAMed #CardioEd

[AsiaIntervention @AsiaInterv]

⚠️ Unvisualised LCA during ACS: what went wrong?

This case by Gulbadin Mufti et al. highlights a rare prepulmonary anomalous LAD mimicking an LM total occlusion, featuring a unique bidirectional bifurcation.
🔗 https://t.co/H723lfqdH5
@APSIC6 @EuroInterventio @PCRonline

[EuroIntervention @EuroInterventio]

In the Multivessel TALENT trial, core lab QCA identified lower device success rates after PCI than visual assessment (88.0% vs 97.4%).
Failure to meet QCA-based criteria was associated with higher rates of lesion-oriented clinical events at 1 year.

READ MORE HERE: https://t.co/WQacYLib8W

[EuroIntervention @EuroInterventio]

🎙️ What are the key takeaways from the SPIRARE II pivotal trial on mechanical thrombectomy for acute intermediate-risk PE?

Dr Aaysha Cader (@aayshacader) & Dr Catalin Toma (@CatalinPToma) discuss the Vertex system, trial design, and the latest clinical safety and effectiveness outcomes.

Find out what these findings mean for your daily interventional practice!

🎧 Listen:
https://t.co/4oS3qWa0kR

📖 Read the Original Research: https://t.co/48xmYGva00

#CardioTwitter #InterventionalCardiology #PulmonaryEmbolism #SPIRAREII

[EuroIntervention @EuroInterventio]

NEW ISSUE OUT

✅CAD management in TAVI;
✅ Prolonged inflation in balloon-expandable
TAVI;
✅ Early outcomes of left-sided AngioVac use;
✅ SPIRARE II;
✅ Life expectancy after aortic valve replacement;
and more

🔗https://t.co/usghBEhWly

@BarbaraStahli @GilbertTangMD @pabl0salinas @KamilBujak12 @cardaioli @fangjonathanx